1-20 of 26
David T. Yang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Reduced Intensity Therapy for Primary Central Nervous System Post-Transplant Lymphoproliferative Disorders (PTLD) Is Associated with Preserved Survival Outcomes: A Twenty-Year Single-Institutional Experience

Bradley Shogo Uyemura, Zhanhai Li, David T Yang, Michael Fallon, Jon S Odorico, Julie E Chang
Journal: Blood
Blood (2024) 144 (Supplement 1): 6447.
https://doi.org/10.1182/blood-2024-193519
Published: 2024
Journal Articles

Addition or Substitution of Acalabrutinib in Intensive Frontline Chemoimmunotherapy for Patients ≤ 70 Years Old with Mantle Cell Lymphoma: Outcomes of the 3-Arm Randomized Phase II Intergroup Trial ECOG-ACRIN EA4181

Nina Wagner-Johnston, Opeyemi Jegede, Stephen E Spurgeon, Kami J. Maddocks, David T Yang, Justin Romanoff, Jonas Paludo, Paolo F. Caimi, Nancy L. Bartlett, Patrick M. Reagan, Yazeed Sawalha, Marc Hoffmann, Boyu Hu, Ashraf R Aziz, Helga Marques, Lale Kosakoglu Shields, John P. Leonard, Jonathan W. Friedberg, Brad S. Kahl
Journal: Blood
Blood (2024) 144 (Supplement 1): 236.
https://doi.org/10.1182/blood-2024-194641
Published: 2024
Journal Articles

Randomized study of induction with bendamustine-rituximab ± bortezomib and maintenance with rituximab ± lenalidomide for MCL

Clinical Trials & Observations
Mitchell R. Smith, Opeyemi A. Jegede, Peter Martin, Brian G. Till, Samir S. Parekh, David T. Yang, Eric D. Hsi, Thomas Witzig, Sandeep Dave, David Scott, Curtis Hanson, Lale Kostakoglu Shields, Nizar Abdel-Samad, Carla Casulo, Nancy L. Bartlett, Paolo F. Caimi, Tareq Al Baghdadi, Kristie A. Blum, Mark D. Romer, David J. Inwards, Rachel E. Lerner, Lynne I. Wagner, Richard F. Little, Jonathan W. Friedberg, John P. Leonard, Brad S. Kahl
Journal: Blood
Blood (2024) 144 (10): 1083–1092.
https://doi.org/10.1182/blood.2024023962
Published: 2024
Includes: Supplemental data
Journal Articles

Randomized Phase 2 Trial of First-Line Bendamustine-Rituximab (BR)-Based Induction Followed By Rituximab (R) ± Lenalidomide (L) Consolidation for Mantle Cell Lymphoma ECOG-ACRIN E1411

Mitchell R Smith, Opeyemi Jegede, Peter Martin, Brian G. Till, Samir Parekh, David T. Yang, Lale Kostakoglu, Carla Casulo, Nancy Bartlett, Paolo F Caimi, Tareq Al Baghdadi, Kami J. Maddocks, Mark D. Romer, David J. Inwards, Rachel E. Lerner, Lynne I. Wagner, Richard Little, Jonathan W. Friedberg, John P. Leonard, Brad S. Kahl
Journal: Blood
Blood (2022) 140 (Supplement 1): 186–188.
https://doi.org/10.1182/blood-2022-170381
Published: 2022
Journal Articles

Durable Remissions with the VcR-CVAD Regimen for Mantle Cell Lymphoma (MCL), Regardless of Age: Long-Term Follow-up of a Wisconsin Oncology Network (WON) Study

Julie E. Chang, MD, Christopher Peterson, MD, Lakeesha L. Carmichael, MS, KyungMann Kim, PhD, David T. Yang, MD, Anne M. Traynor, MD, Jae E. Werndli, BSc, MSc, Michael Huie, MD, Thomas McFarland, MD, Michael Volk, MD, Jules H. Blank, MD, Natalie S. Callander, MD, Walter L. Longo, MD, Brad S. Kahl, MD
Journal: Blood
Blood (2016) 128 (22): 149.
https://doi.org/10.1182/blood.V128.22.149.149
Published: 2016
Journal Articles

Orchestrating Developmental Signaling to Balance Erythroblast Proliferation and Differentiation

Skye C McIver, PhD, Koichi R Kasumura, MD PhD, Elsa Davids, Yoon-A Kang, PhD, Peng Liu, PhD, David T Yang, MD, Emery H Bresnick, PhD
Journal: Blood
Blood (2016) 128 (22): 699.
https://doi.org/10.1182/blood.V128.22.699.699
Published: 2016
Journal Articles

Follicular lymphoma: evolving therapeutic strategies

Clinical Trials & Observations
Brad S. Kahl, David T. Yang
Journal: Blood
Blood (2016) 127 (17): 2055–2063.
https://doi.org/10.1182/blood-2015-11-624288
Published: 2016
Journal Articles

Mechanism Governing Heme Synthesis Reveals a GATA Factor-Heme Circuit That Controls Differentiation

Emery H Bresnick, PhD, Nobuyuki Tanimura, Eli Miller, Kazuhiko Igarashi, MD PhD, David T Yang, MD, Judith Burstyn, Colin Dewey
Journal: Blood
Blood (2015) 126 (23): 161.
https://doi.org/10.1182/blood.V126.23.161.161
Published: 2015
Journal Articles

Synergistic Co-Targeting of BTK and BCL2 in Mantle Cell Lymphoma

Yangguang Li, PhD, Myriam N. Bouchlaka, BS, PhD, Kreg Grindle, Brad S Kahl, MD, Shigeki Miyamoto, David T Yang, MD, Christian M. Capitini, MD, Lixin Rui, PhD
Journal: Blood
Blood (2015) 126 (23): 708.
https://doi.org/10.1182/blood.V126.23.708.708
Published: 2015
Journal Articles

Induced Pluripotent Stem Cell Model of Chronic Myeloid Leukemia Revealed Olfactomedin 4 As a Novel Survival Factor for Primitive Leukemia Cells

Kran Suknuntha, MD PhD, Yuki Ishii, PhD, Kejin Hu, PhD, Mcintosch Brayan, PhD, David T. Yang, MD, Scott Swanson, Ron Stewart, PhD, Jean YJ Wang, PhD, James Thomson, PhD DVM, Igor Slukvin, MD PhD
Journal: Blood
Blood (2014) 124 (21): 397.
https://doi.org/10.1182/blood.V124.21.397.397
Published: 2014
Journal Articles

The RNA-Degrading Exosome Complex Is an Endogenous Suppressor of Erythroid Maturation

Skye C McIver, PhD, Yoon-A Kang, PhD, Andrew W DeVilbiss, BS, Chelsea A O'Driscoll, BS, David T. Yang, MD, Saghi Ghaffari, MD PhD, Emery H Bresnick, PhD
Journal: Blood
Blood (2014) 124 (21): 2659.
https://doi.org/10.1182/blood.V124.21.2659.2659
Published: 2014
Journal Articles

Lymphoproliferative disorder with Auer rod–like inclusions

Matthew J. Oberley, David T. Yang
Journal: Blood
Blood (2014) 124 (16): 2607.
https://doi.org/10.1182/blood-2014-07-587683
Published: 2014
Journal Articles

Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis

Clinical Trials & Observations
Adam M. Petrich, Mitul Gandhi, Borko Jovanovic, Jorge J. Castillo, Saurabh Rajguru, David T. Yang, Khushboo A. Shah, Jeremy D. Whyman, Frederick Lansigan, Francisco J. Hernandez-Ilizaliturri, Lisa X. Lee, Stefan K. Barta, Shruthi Melinamani, Reem Karmali, Camille Adeimy, Scott Smith, Neil Dalal, Chadi Nabhan, David Peace, Julie Vose, Andrew M. Evens, Namrata Shah, Timothy S. Fenske, Andrew D. Zelenetz, Daniel J. Landsburg, Christina Howlett, Anthony Mato, Michael Jaglal, Julio C. Chavez, Judy P. Tsai, Nishitha Reddy, Shaoying Li, Caitlin Handler, Christopher R. Flowers, Jonathon B. Cohen, Kristie A. Blum, Kevin Song, Haowei (Linda) Sun, Oliver Press, Ryan Cassaday, Jesse Jaso, L. Jeffrey Medeiros, Aliyah R. Sohani, Jeremy S. Abramson
Journal: Blood
Blood (2014) 124 (15): 2354–2361.
https://doi.org/10.1182/blood-2014-05-578963
Published: 2014
Includes: Supplemental data
Journal Articles

TPL2 kinase regulates the inflammatory milieu of the myeloma niche

Chelsea Hope, Samuel J. Ollar, Erika Heninger, Ellen Hebron, Jeffrey L. Jensen, Jaehyup Kim, Ioanna Maroulakou, Shigeki Miyamoto, Catherine Leith, David T. Yang, Natalie Callander, Peiman Hematti, Marta Chesi, P. Leif Bergsagel, Fotis Asimakopoulos
Journal: Blood
Blood (2014) 123 (21): 3305–3315.
https://doi.org/10.1182/blood-2014-02-554071
Published: 2014
Includes: Supplemental data
Journal Articles

Phase 2 study of VcR-CVAD with maintenance rituximab for untreated mantle cell lymphoma: an Eastern Cooperative Oncology Group study (E1405)

Clinical Trials & Observations
Julie E. Chang, Hailun Li, Mitchell R. Smith, Randy D. Gascoyne, Elisabeth M. Paietta, David T. Yang, Ranjana H. Advani, Sandra J. Horning, Brad S. Kahl
Journal: Blood
Blood (2014) 123 (11): 1665–1673.
https://doi.org/10.1182/blood-2013-08-523845
Published: 2014
Includes: Supplemental data
Journal Articles

Neutrophil alphabet

Adam S. Morgan, David T. Yang
Journal: Blood
Blood (2013) 121 (18): 3546.
https://doi.org/10.1182/blood-2012-12-472357
Published: 2013
Journal Articles

Mature Results From ECOG Study E1405 – A Phase II Study of VcR-CVAD with Maintenance Rituximab for Previously Untreated Mantle Cell Lymphoma

Brad S. Kahl, M.D., Hailun Li, MS, Mitchell R Smith, MD, PhD, Randy D. Gascoyne, MD, David T. Yang, MD, Elisabeth Paietta, PhD, Ranjana H. Advani, MD, Sandra J. Horning, M.D.
Journal: Blood
Blood (2012) 120 (21): 153.
https://doi.org/10.1182/blood.V120.21.153.153
Published: 2012
Journal Articles

SOX11 Directly Represses Wnt/β-Catenin Signaling and Identifies a Subgroup of Mantle Cell Lymphoma Patients with Improved Survival with Intensive Treatment

Pei-Yu Kuo, MS, Violetta V. Leshchenko, PhD, Melissa J Fazzari, PhD, Tobias A. Gellen, Javeed Iqbal, M.Sc, PhD, Stefanie Baumgartner-Wennerholm, MD, Lina Nygren, MD, K. Stephen Suh, PhD, Andre Goy, MD, David T. Yang, MD, Wing-Chung Chan, MD, Brad S Kahl, MD, Amit Verma, MD, Randy D. Gascoyne, MD, Eva Kimby, M.D., Ph.D., Birgitta Sander, MD, Ph.D., B. Hilda Ye, PhD, Ari Melnick, MD, Samir Parekh, MD
Journal: Blood
Blood (2012) 120 (21): 895.
https://doi.org/10.1182/blood.V120.21.895.895
Published: 2012
Journal Articles

Microscale functional cytomics for studying hematologic cancers

e-blood
Edmond W. K. Young, Chorom Pak, Brad S. Kahl, David T. Yang, Natalie S. Callander, Shigeki Miyamoto, David J. Beebe
Journal: Blood
Blood (2012) 119 (10): e76–e85.
https://doi.org/10.1182/blood-2011-10-384347
Published: 2012
Includes: Supplemental data
Journal Articles

High-Resolution Chromatin Immunoprecipitation (ChIP) Sequencing Identifies Novel Binding Targets and Prognostic Role for SOX11 in Mantle Cell Lymphoma

Pei-Yu Kuo, MS, Violetta V. Leshchenko, PhD, Tobias A. Gellen, Netha Ulahannan, MS, Paul Zumbo, BA, BS, Christopher E. Mason, PhD, Wyndham H. Wilson, MD, PhD, Adrian Wiestner, MD, PhD, K. Stephen Suh, PhD, Andre Goy, MD, David T. Yang, MD, Brad S. Kahl, MD, Randy D. Gascoyne, MD, Ari Melnick, MD, Samir Parekh, MD
Journal: Blood
Blood (2011) 118 (21): 585.
https://doi.org/10.1182/blood.V118.21.585.585
Published: 2011